四肢骨巨细胞瘤伴病理性骨折的治疗进展  

Treatment progress of giant cell tumor of limbs with pathological fracture

作　　者：文立 王守丰[1] WEN Li;WANG Shoufeng(Department of Orthopedics,Nanjing Drum Tower Hospital,the Af]~liated Hospital of Nanjing Ur~iversity Medical School,Nanjig 210008,China)

机构地区：[1]南京大学医学院附属鼓楼医院骨科,江苏南京210008

出　　处：《中国肿瘤外科杂志》2018年第2期72-76,共5页Chinese Journal of Surgical Oncology

摘　　要：骨巨细胞瘤(GCTB)好发于肢体骨端,约占原发性骨肿瘤5%～8%,约占所有良性骨肿瘤15%。部分患者初诊时伴有病理性骨折。病理性骨折的分型与术前评估决定手术策略及预后。GCTB伴病理性骨折的治疗,主要有肿瘤刮除辅助灭活填充或扩大切除后功能重建两种治疗方式。文章就四肢骨巨细胞瘤伴病理性骨折发生率、术前评估与分型、治疗方法的选择、复发率及并发症进行概述。Giant cell tumor of bone（ GCT） occurs at the extremities of the extremities. It accounts for 5% to 8% of the primary bone tumors,accounting for 15% of all benign bone tumors. Some patients were diagnosed with pathological fracture when they were first diagnosed. Surgical strategy and prognosis are determined by pathological fracture classification and preoperative evaluation. Surgical treatment of GCT with pathological fracture includes two ways： tumor curettage,inactivation filling or functional reconstruction after total resection. This article summarizes the incidence,preoperative evaluation and classification,treatment options,recurrence rate and complications of giant cell tumor of extremities with pathological fracture.

关 键 词：骨巨细胞瘤 病理性骨折 发生率 术前评估 手术治疗 

分 类 号：R738.1[医药卫生—肿瘤]